Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Frontiers in Oncology
|
April 17, 2023
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab
Andrea Duminuco, Alessandra Romano, Dario Leotta, et al.
Hematology Reports
|
September 23, 2024
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects
Manlio Fazio, Chiara Maria Catena Sorbello, Vittorio Del Fabro, et al.
European Journal of Haematology
|
January 5, 2011
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells
Cesarina Giallongo, Piera La Cava, Daniele Tibullo, et al.
Journal of Clinical Medicine
|
January 8, 2025
Emergencies in Hematology: Why, When and How I Treat?
Andrea Duminuco, Vittorio Del Fabro, Paola De Luca, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape
Andrea Duminuco, Patrick Harrington, Vittorio Del Fabro, et al.
Cancers
|
August 26, 2023
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study
Vittorio Del Fabro, Mary Ann Di Giorgio, Valerio Leotta, et al.
Cancers
|
March 10, 2022
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection
Alessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
European Journal of Haematology
|
November 24, 2025
Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life Study
Andrea Duminuco, Vittorio Del Fabro, Gabriella Santuccio, et al.
Journal of Clinical Medicine
|
October 19, 2019
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
Marina Silvia Parisi, Salvatore Leotta, Alessandra Romano, et al.
Diseases (Basel, Switzerland)
|
February 26, 2026
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers
Vittorio Del Fabro, Lara Gullo, Giuliana Giunta, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Frontiers in Oncology
|
April 17, 2023
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab
Andrea Duminuco, Alessandra Romano, Dario Leotta, et al.
Hematology Reports
|
September 23, 2024
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects
Manlio Fazio, Chiara Maria Catena Sorbello, Vittorio Del Fabro, et al.
European Journal of Haematology
|
January 5, 2011
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells
Cesarina Giallongo, Piera La Cava, Daniele Tibullo, et al.
Journal of Clinical Medicine
|
January 8, 2025
Emergencies in Hematology: Why, When and How I Treat?
Andrea Duminuco, Vittorio Del Fabro, Paola De Luca, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape
Andrea Duminuco, Patrick Harrington, Vittorio Del Fabro, et al.
Cancers
|
August 26, 2023
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study
Vittorio Del Fabro, Mary Ann Di Giorgio, Valerio Leotta, et al.
Cancers
|
March 10, 2022
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection
Alessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
European Journal of Haematology
|
November 24, 2025
Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life Study
Andrea Duminuco, Vittorio Del Fabro, Gabriella Santuccio, et al.
Journal of Clinical Medicine
|
October 19, 2019
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
Marina Silvia Parisi, Salvatore Leotta, Alessandra Romano, et al.
Diseases (Basel, Switzerland)
|
February 26, 2026
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers
Vittorio Del Fabro, Lara Gullo, Giuliana Giunta, et al.
Page
of 4